NM_001897.5:c.914C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_001897.5(CSPG4):​c.914C>T​(p.Thr305Met) variant causes a missense change. The variant allele was found at a frequency of 0.00903 in 142,802 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAd4), which may indicate mosaicism or somatic mutations in the reference population data. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0090 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0048 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CSPG4
NM_001897.5 missense

Scores

8
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 5.15

Publications

7 publications found
Variant links:
Genes affected
CSPG4 (HGNC:2466): (chondroitin sulfate proteoglycan 4) A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. [provided by RefSeq, Jul 2008]
CSPG4 Gene-Disease associations (from GenCC):
  • schizophrenia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003302157).
BP6
Variant 15-75690151-G-A is Benign according to our data. Variant chr15-75690151-G-A is described in ClinVar as Benign. ClinVar VariationId is 402567.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSPG4NM_001897.5 linkc.914C>T p.Thr305Met missense_variant Exon 3 of 10 ENST00000308508.5 NP_001888.2 Q6UVK1
CSPG4XM_047432196.1 linkc.-149C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 3 of 10 XP_047288152.1
CSPG4XM_047432196.1 linkc.-149C>T 5_prime_UTR_variant Exon 3 of 10 XP_047288152.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSPG4ENST00000308508.5 linkc.914C>T p.Thr305Met missense_variant Exon 3 of 10 1 NM_001897.5 ENSP00000312506.5 Q6UVK1

Frequencies

GnomAD3 genomes
AF:
0.00900
AC:
1284
AN:
142732
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0312
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00399
Gnomad ASJ
AF:
0.00293
Gnomad EAS
AF:
0.000775
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.000663
Gnomad MID
AF:
0.00685
Gnomad NFE
AF:
0.00179
Gnomad OTH
AF:
0.00914
GnomAD2 exomes
AF:
0.00786
AC:
1926
AN:
244940
AF XY:
0.00666
show subpopulations
Gnomad AFR exome
AF:
0.0727
Gnomad AMR exome
AF:
0.00501
Gnomad ASJ exome
AF:
0.00394
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.00227
Gnomad NFE exome
AF:
0.00526
Gnomad OTH exome
AF:
0.00502
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00477
AC:
6847
AN:
1435236
Hom.:
0
Cov.:
34
AF XY:
0.00465
AC XY:
3320
AN XY:
714496
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0634
AC:
1722
AN:
27180
American (AMR)
AF:
0.00382
AC:
167
AN:
43700
Ashkenazi Jewish (ASJ)
AF:
0.00237
AC:
61
AN:
25686
East Asian (EAS)
AF:
0.000462
AC:
18
AN:
38948
South Asian (SAS)
AF:
0.00116
AC:
99
AN:
85570
European-Finnish (FIN)
AF:
0.00145
AC:
76
AN:
52256
Middle Eastern (MID)
AF:
0.0125
AC:
69
AN:
5524
European-Non Finnish (NFE)
AF:
0.00393
AC:
4313
AN:
1097686
Other (OTH)
AF:
0.00549
AC:
322
AN:
58686
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.250
Heterozygous variant carriers
0
959
1918
2876
3835
4794
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
228
456
684
912
1140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00903
AC:
1290
AN:
142802
Hom.:
0
Cov.:
33
AF XY:
0.00911
AC XY:
637
AN XY:
69902
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0313
AC:
1065
AN:
34032
American (AMR)
AF:
0.00398
AC:
59
AN:
14810
Ashkenazi Jewish (ASJ)
AF:
0.00293
AC:
10
AN:
3418
East Asian (EAS)
AF:
0.000777
AC:
4
AN:
5148
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4788
European-Finnish (FIN)
AF:
0.000663
AC:
7
AN:
10560
Middle Eastern (MID)
AF:
0.00741
AC:
2
AN:
270
European-Non Finnish (NFE)
AF:
0.00179
AC:
120
AN:
66874
Other (OTH)
AF:
0.00904
AC:
18
AN:
1992
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.253
Heterozygous variant carriers
0
174
347
521
694
868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0138
Hom.:
0
ExAC
AF:
0.0206
AC:
2502

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.12
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.27
T
Eigen
Uncertain
0.46
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.84
T
MetaRNN
Benign
0.0033
T
MetaSVM
Uncertain
-0.013
T
MutationAssessor
Benign
1.9
L
PhyloP100
5.2
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.50
Sift
Uncertain
0.014
D
Sift4G
Uncertain
0.031
D
Polyphen
0.99
D
Vest4
0.24
MPC
0.91
ClinPred
0.015
T
GERP RS
5.3
Varity_R
0.079
gMVP
0.62
Mutation Taster
=74/26
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76827801; hg19: chr15-75982492; COSMIC: COSV57889988; API